Nexalin Technology Inc stock is traded at $1.44, with a volume of 14,201. It is down -4.00% in the last 24 hours and down -60.33% over the past month. Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Previous Close:
$1.50
Open:
$1.46
24h Volume:
14,201
Relative Volume:
0.54
Market Cap:
$1.65M
Revenue:
$275.60K
Net Income/Loss:
-$8.33M
P/E Ratio:
-
EPS:
-$0.4619
Net Cash Flow:
-$5.40M
1W Performance:
-6.49%
1M Performance:
-60.33%
6M Performance:
-86.38%
1Y Performance:
-96.42%
1-Day Range:
$1.42$1.52
1-Week Range:
$1.31$1.60
52-Week Range:
$1.31$40.80
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology IncSector
HealthcareIndustry
Medical DevicesPhone
(832) 260-0222Address
1776 YORKTOWN, HOUSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS